• PR-619: Practical Guidance for Deubiquitylating Enzyme Inhib

  2026-07-20

  PR-619 is a cell-permeable, reversible inhibitor targeting a broad range of cysteine-dependent deubiquitinating enzymes (DUBs), facilitating the study of ubiquitination dynamics in cell-based assays without direct proteasomal inhibition. It is best suited for workflows investigating the accumulation of ubiquitinated proteins or dissecting autophagy and protein degradation pathways, but requires careful solubilization and dosing strategies to avoid off-target cytotoxicity.

• CCK-8 Modulates Opioid-Dependent Anxiety in Morphine Withdra

  2026-07-20

  This study identifies cholecystokinin octapeptide (CCK-8) as a regulator of anxiety-like behavior in morphine-withdrawal rats, revealing a novel endogenous opioid-dependent anxiolytic mechanism mediated via CCK1 receptors. The findings highlight new neurobiological targets for opioid addiction and withdrawal research, with implications for the development of therapies addressing negative affect during abstinence.

• PDI Inhibition Enhances Panobinostat Efficacy in Multiple My

  2026-07-19

  This study demonstrates that the protein disulfide isomerase (PDI) inhibitor LTI6426 significantly enhances the anti-tumor activity of panobinostat (Pano) in preclinical multiple myeloma models. The findings support a new combination approach that may permit lower, better-tolerated doses of panobinostat, with implications for optimizing epigenetic therapies in resistant disease.

• Targeting eIF4F, AKT1, and EZH2 in BRAFV600E Melanoma: Syner

  2026-07-18

  This study demonstrates that combinatorial inhibition of the eIF4F complex, AKT1, and EZH2 overcomes resistance to targeted therapies in BRAFV600E mutant melanoma cells. The findings highlight a coordinated signaling network underpinning drug resistance and suggest that dual or triple inhibitor strategies may significantly enhance anticancer efficacy in refractory melanoma models.

• Structural Insights into Nipah Virus Polymerase Complex Func

  2026-07-17

  The reference study elucidates the high-resolution structure of the Nipah virus L-P polymerase complex, revealing key mechanistic details of viral RNA synthesis and protein interactions. These findings provide a critical foundation for rational antiviral drug design targeting the replication machinery of henipaviruses and related RNA viruses.

• Hydroxychloroquine Sulfate for Autoimmune Disease Research P

  2026-07-17

  Hydroxychloroquine Sulfate (SKU B4874) enables targeted inhibition of autophagy and TLR7/9 signaling in autoimmune disease research, supporting reproducible studies in models of systemic lupus erythematosus and rheumatoid arthritis. The compound is optimized for aqueous-based workflows requiring short-term solution use and is not suitable for protocols needing organic solvent compatibility or long-term storage.

• Single-Nucleus Profiling Reveals ATRNL1's Role in Atrial Fib

  2026-07-16

  The reference study applies large-scale single-nucleus RNA sequencing to human atrial tissue, uncovering ATRNL1 as a key regulator in atrial fibrillation (AF) pathophysiology. These findings highlight new molecular targets for AF therapy and suggest avenues for future research into cardiac conduction and stress response mechanisms.

• Gemcitabine HCl in Pancreatic Cancer: Mechanistic Insight &

  2026-07-16

  This thought-leadership article provides translational researchers with a comprehensive examination of Gemcitabine HCl (4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one hydrochloride) in pancreatic cancer research. We bridge molecular mechanisms, innovative imaging protocols, and workflow strategy, with actionable guidance for advancing preclinical studies. Moving beyond product basics, we synthesize evidence from multianimal MRI protocols and recent high-throughput workflow innovations, offering a forward-looking vision for rigorous, data-driven tumor suppression studies.

• Proteoform-Specific Drug Interactions in Native Cell Signali

  2026-07-15

  This article reviews how the reference study pioneers direct characterization of proteoform-specific interactions in native membrane environments using advanced mass spectrometry. Key findings reveal how post-translational modifications and alternative splicing shape the specificity and off-target effects of phosphodiesterase inhibitors, with major implications for rational drug design in vascular and vision-related research.

• 2-D08 (2’,3’,4’-trihydroxyflavone): Precision SUMOylation In

  2026-07-15

  2-D08 (2’,3’,4’-trihydroxyflavone) is a highly selective small molecule inhibitor that uniquely blocks SUMOylation at the E2-substrate interface without off-target effects on ubiquitination. Its distinct mechanism unlocks new experimental possibilities for dissecting SUMO-dependent mitophagy and cancer pathways with minimal confounding variables.

• Mifepristone (RU486): Precision Modulation of Cancer Cell Fa

  2026-07-14

  Explore how Mifepristone (RU486) enables advanced, selective control of cancer cell proliferation and reproductive signaling. This article reveals nuanced mechanisms and comparative insights for researchers seeking to harness RU486’s unique properties in oncology and reproductive biology.

• Alternariol in Mycotoxin Research: Workflows, Insights & Tro

  2026-07-14

  Alternariol (AOH) is a pivotal tool for modeling toxin-induced liver fibrosis and dissecting cytochrome P450-mediated metabolism. This article delivers evidence-based protocols, practical troubleshooting strategies, and new insights into the mechanisms and mitigation of AOH hepatotoxicity.

• ABT-737: Shaping Apoptosis Research with BCL-2 Protein Inhib

  2026-07-13

  Discover how ABT-737, a benchmark BCL-2 protein inhibitor, empowers translational researchers to dissect and modulate apoptosis pathways in cancer models. This thought-leadership article delivers mechanistic context, strategic guidance, and actionable protocol insights, highlighting the synergy between recent scientific breakthroughs and advanced small-molecule tools.

• Dibutyryl-cAMP, Sodium Salt: Optimizing cAMP Pathway Assays

  2026-07-13

  Dibutyryl-cAMP, sodium salt (DBcAMP) empowers researchers with precise, reproducible modulation of the cAMP signaling pathway—enabling advanced studies in cell differentiation, inflammation, and reproductive biology. This article delivers actionable protocol guidance, troubleshooting, and practical insights drawn from cutting-edge research and real-world laboratory scenarios.

• DFO (9H-1,8-Diazafluoren-9-one): Sensitivity and Reproducibi

  2026-07-12

  This article provides scenario-driven guidance for biomedical researchers and lab technicians utilizing DFO (9H-1,8-Diazafluoren-9-one) (SKU C6997) in cell viability and cytotoxicity workflows. Drawing on practical laboratory challenges, we demonstrate how APExBIO’s high-purity DFO enhances assay sensitivity, reproducibility, and workflow integration, with evidence-backed recommendations for protocol optimization.

455 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page